Hepatic Transport Mechanisms, Intrahepatic Cholestasis and Gallstone
Disease.- Liver Transplantation: State of the Art.- Mathematical Models for
the Study of Liver Metabolism.- Mechanisms of Hepatic Fatty Acid Uptake.-
Vesicular Transport of Fluid Phase Markers by Hepatocytes.- The Hepatic
Uptake of Organic Anions: an Overview.- Mechanisms of Transport of
Tauroconjugated Bile Acids in the Hepatocyte: Functional Significance.-
Determinants of Biliary Cholesterol Secretion.- The Enterohepatic Circulation
of Sulfated and Nonsulfated Bile Acids.- Esterogens and Bile Secretion.-
Transport of UDPG in Vitro and Reversal of Ethanol-Induced Effects.-
Associated Factors in Gallstone Disease.- Epidemiology of Gallstone Disease
in Hungary.- The Role of the Gallbladder in Cholesterol Gallstone
Pathogenesis.- Mechanism of Gallstone Formation in Obese Subjects.- Medical
Treatment of Cholesterol Gallstones: Present and Future.- Bile Acid Treatment
of Cholesterol Gallstones: A Reappraisal.- Biliary Lipid Composition after
Endoscopic Sphincterotomy in Postcholecystectomy Patients: Effect of
Short-Term Ursodeoxycholic Acid Administration.- Concluding Remarks.-
Assessment of Liver Function.- Drug-Induced Liver Injury.- Biochemical Liver
Tests: Recent Developments and Challenges.- Should Serum Bile Acid
Determinations be performed Routinely in Patients with Liver Disease?.-
Clinical Significance of Serum Bilirubins: Recent Advances.- Enzyme Pattern
Changes in Preneoplastic and Neoplastic Lesions of the Liver.- The Value of
Quantitation of Liver Function.- Quantitation of Liver Function: Antipyrine
Metabolism, an Update.- Antipyrine Clearance: Evaluation of Simplified
Methods in Chronic Liver Diseases.- Preoperative Care of Adult Patients
Chosen for Liver Transplantation.- Assessment of Liver Function Before and
After Liver Transplantation.- Hormones and Liver: Some Aspects of the
Problem.- Effects of Thyroid Hormone Administration and of Thyroidectomy on
the Metabolism of Bilirubin in Rats.- Comparison of Some Parameters of the
Drug-Metabolizing Enzyme System and Liver Function Tests in Different Hepatic
Diseases.- Interaction of Ethanol with Hepatic Drug Metabolism.- Antioxidant
and Immunomodulant Effect of Hepatoprotective Drugs.- Stimulating Influence
of a Flavonolignane Derivative on Proliferation, RNA Synthesis and Protein
Synthesis in Liver Cells.- Renal Functional Impairment in Cirrhosis.-
Pathophysiology of Cirrhotic Ascites.- Treatment of Ascites.- Low-Sodium Diet
in the Management of Ascites in the Cirrhotic Patient.- Treatment of
Refractory Ascites by Concentrated Ascitic Fluid Reinfusion.- Concluding
Remarks.- Management of Liver Disease.- Liver and Aging.- Prognosis of
Advanced Liver Disease.- Virus and Host Factors in the Evolution of Chronic
Hepatitis Type B: Choice of Treatment.- Antiviral Treatment of Chronic
Hepatitis.- Autoimmune Hepatitis: Diagnosis and Treatment.- Serum
?2-microglobulin and Anti- ?2m Antibodies in Chronic Liver Disease.-
Treatment of Liver Cirrhosis.- Drug Therapy for Alcoholic Liver Disease.-
Silymarin Treatment in Patients with Cirrhosis of the Liver-A Prospective
Study.- Protein Malnutrition in Chronic Liver Disease: Corrective Measures.-
The Management of Primary Biliary Cirrhosis.- Impaired Calcitonin Response to
Intravenous Calcium Load in Primary Biliary Cirrhosis.- Prevention of Upper
Gastrointestinal Bleeding in Cirrhotic Patients.- Prophylactic Treatment of
First Variceal Bleeding in Cirrhotics with Nadolol or Ranitidine: A
Prospective Randomized Study.- Hemodynamic and Clinical Evaluation of Nadolol
in the Treatment of Portal Hypertension in Patients with Cirrhosis.- The GABA
Hypothesis of the Pathogenesis of Hepatic Encephalopathy: Current Status.-
Lactitol in the Prevention of Recurrent Hepatic Encephalopathy in Shunted
Cirrhotic Patients. Preliminary Results of a Controlled Trial.- Concluding
Remarks.
